Publications

5808 Results

Cytogenetic and flow cytometric results in advanced renal cell carcinoma: a Southwest Oncology Group study

Authors
RP Whitehead;C Tangen;SR Wolman;RC Flanigan;TV Shankey;ML Slovak;ED Crawford
Journal / Conference
Proc of the American Society of Clinical Oncology 21:147b(#2400)
Year
2002
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9023

HLA-A2 and/or HLA-C3 expression defines a subset of T3N0 melanoma patients with improved overall survival from melacine vaccine: an updated analysis of SWOG 9035.

Authors
JA Sosman;JM Unger;PY Liu;R Kempf;L Flaherty;J Thompson;VK Sondak
Journal / Conference
Proc of the American Society of Clinical Oncology 21:340a(#1359)
Year
2002
Research Committee(s)
Melanoma
Study Number(s)
SWOG-9035

Phase III comparison of adjuvant high-dose doxorubicin plus cyclophosphamide (AC) versus sequential doxorubicin followed by chyclophosphamide (A->C) in breast cancer patients with 0-3 positive nodes (Intergroup 0137)

Authors
CM Haskell;SJ Green;GW Sledge Jr;CL Shapiro;JN Ingle;D Lew;S Martino;R Livingston;CK Osborne
Journal / Conference
Proc of the American Society of Clinical Oncology 21:36a(#142)
Year
2002
Research Committee(s)
Breast
Study Number(s)
SWOG-9313

Induction chemotherapy followed by chemoradiation for organ preservation in patients (pts) with advanced resectable cancer of the base of tongue (BOT) and hypopharynx (HP): a Southwest Oncology Group trial.

Authors
S Urba;J Moon;M LeBlanc;J Forman;D Adelstein;P Giri;E Hanna;J Ensley;D Schuller
Journal / Conference
Proc of the American Society of Clinical Oncology 21:230a(#919)
Year
2002
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-9451

Excellent 2-year survival in women with optimally-debulked ovarian cancer treated with intraperitoneal and intravenous chemotherapy: a SWOG-ECOG-NCIC study (S9619)

Authors
ML Rothenberg;PY Liu;S Wilczynski;PS Braly;S Wadler;G Stuart;EV Hannigan;AJ Bonebrake;DS Alberts;M Markman
Journal / Conference
Proc of the American Society of Clinical Oncology 21:203a(#809)
Year
2002
Research Committee(s)
Gynecologic
Study Number(s)
S9619

Anti-androgen withdrawal in prostate cancer: results from SWOG 9426

Authors
AO Sartor;C Tangen;M Hussain;M Eisenberger;ED Crawford
Journal / Conference
Proc of the American Society of Clinical Oncology 21:197a(#785)
Year
2002
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9426

Continuous infusion (CI) 5 fluorouracil (5FU), leucovorin (LV), mitomycin C (mito C) and dipyridamole (D) in patients with locally advanced unresectable pancreatic adenocarcinoma-a phase II trial of the Southwest Oncology Group

Authors
WH Isacoff;J Benedetti;JS Macdonald;JL Abbruzzese
Journal / Conference
Proc of the American Society of Clinical Oncology 21:137a(#544)
Year
2002
Research Committee(s)
Gastrointestinal
Study Number(s)
S9700

Concurrent carboplatin/etoposide and radiation followed by paclitaxel consolidation for poor risk stage III non-small cell lung cancer: a Southwest Oncology Group (SWOG) phase II trial (S9712)

Authors
A Davies;D Lau;J Crowley;B Leigh;DR Gandara
Journal / Conference
Proc of the American Society of Clinical Oncology 21:298a(#1191)
Year
2002
Research Committee(s)
Lung
Study Number(s)
S9712

Phase II (SWOG 9713) trial of cisplatin/etoposide (PE) and concurrent radiotherapy (XRT) followed by paclitaxel/carboplatin (TC) consolidation for limited small cell lung cancer (LSCLC)

Authors
MJ Edelman;K Chansky;B Leigh;J Crowley;DR Gandara
Journal / Conference
Proc of the American Society of Clinical Oncology 21:303a(#1210)
Year
2002
Research Committee(s)
Lung
Study Number(s)
S9713

Evaluation of vinorelbine tartrate (navelbine) in patients with dissemminated malignant melanoma and at least one prior systemic therapy, phase II: a Southwest Oncology Group Study

Authors
J Moon;RP Whitehead;S McCachren;E Hersh;LE Flaherty;VK Sondak
Journal / Conference
Proc of the American Society of Clinical Oncology 21:347a(#1386)
Year
2002
Research Committee(s)
Melanoma
Study Number(s)
S9804